Patients with type 2 diabetes and atopic dermatitis show higher risk for cardiovascular events, but GLP-1 agonists reduce the ...

The study tests upadacitinib, an oral tablet, and dupilumab, a subcutaneous injection, to determine their effectiveness in treating atopic dermatitis. The goal is to assess whether upadacitinib can ...

Nektar Therapeutics is fairly valued based on rNPV modeling, but multiple near-term catalysts could drive upside. Learn why ...

Discover a study showing how online clustered nursing care improves symptoms and enhances sleep quality in adults with atopic dermatitis.

Synthetic generation replicates key clinical patterns from real-world data, enabling valid analyses with fewer patients.

Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused ...

Across the recent three months, 13 analysts have shared their insights on Incyte (INCY) , expressing a variety of opinions ...

The team from the University of Queensland used stem cells to create a replica of the human skin, which had blood vessels, ...

University of Queensland (UQ) researchers have become the first in the world to successfully grow fully functioning human ...

Panelists discuss the challenges of biologic access in hidradenitis suppurativa due to utilization management policies like step therapy, emphasizing the need for patient education, strategic planning ...

The global over the counter (OTC) drugs market size was valued at USD 129.80 billion in 2024 and is expected to grow at a CAGR of 6.72% from 2025 to ...

In nine studies (76 patients), the anti-IgE monoclonal antibody omalizumab (Xolair), given every 2-4 weeks at doses ranging ...